Michel Baijot

Bioengineer, PhD, Michel Baijot is a life science executive bringing over 30 years of experience in building biological businesses with significant contributions in strategy, licensing, M&A and technology transfer. His positions with biotech and big pharmaceutical companies as well as his tangible achievements reflect an in-depth knowledge of the business environment in both developed and emerging markets.He is currently Chairman or Board Director of White Fund, RNAlead, Radiomics, 20Med Therapeutics. His previous positions include Executive Director Europe at Serum Institute of India, Head of Cipla Global Vaccine, Chief Business Officer at Janssen/Crucell, Vice President Worldwide Strategic Alliances and Business Development at GSK Vaccines , Vice President Business Development at Innogenetics, Corporate Director at bioMérieux USA. He was Chairman of the Belgian Biotech Association during 5 years.